WO2010082785A3 - 경구용 약학적 조성물 - Google Patents
경구용 약학적 조성물 Download PDFInfo
- Publication number
- WO2010082785A3 WO2010082785A3 PCT/KR2010/000268 KR2010000268W WO2010082785A3 WO 2010082785 A3 WO2010082785 A3 WO 2010082785A3 KR 2010000268 W KR2010000268 W KR 2010000268W WO 2010082785 A3 WO2010082785 A3 WO 2010082785A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- drug
- liver
- metabolised
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
간에서 대사되는 약물; 및 간보호제를 포함하는 경구용 약학적 조성물을 제공한다. 본 발명의 조성물은 간에서 대사되는 약물 투여시 약물성 간독성작용을 예방하거나 경감시킬 수 있다.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14529609P | 2009-01-16 | 2009-01-16 | |
| US61/145,296 | 2009-01-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010082785A2 WO2010082785A2 (ko) | 2010-07-22 |
| WO2010082785A3 true WO2010082785A3 (ko) | 2010-11-25 |
Family
ID=42340217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2010/000268 WO2010082785A2 (ko) | 2009-01-16 | 2010-01-15 | 경구용 약학적 조성물 |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2010082785A2 (ko) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100310979B1 (ko) * | 1999-03-25 | 2001-10-17 | 김상조 | 간질환 예방 및 치료용 생약조성물 |
| KR100372561B1 (ko) * | 2000-11-28 | 2003-02-15 | 한국생명공학연구원 | 천연 생약제 추출물을 포함하는 숙취해소용 조성물 및이를 유효성분으로 함유하는 건강보조식품 |
| WO2005072758A1 (en) * | 2004-01-31 | 2005-08-11 | Kiyoung Kim | Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof |
| KR20070034146A (ko) * | 2005-09-23 | 2007-03-28 | 대우약품공업주식회사 | 항간독성 조성물 |
| WO2008044862A1 (en) * | 2006-10-10 | 2008-04-17 | Hanall Pharmaceutical Co., Ltd. | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| KR20100008356A (ko) * | 2008-07-15 | 2010-01-25 | 한올제약주식회사 | 칼슘채널길항제를 포함하는 약제학적 제제 |
-
2010
- 2010-01-15 WO PCT/KR2010/000268 patent/WO2010082785A2/ko active Application Filing
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100310979B1 (ko) * | 1999-03-25 | 2001-10-17 | 김상조 | 간질환 예방 및 치료용 생약조성물 |
| KR100372561B1 (ko) * | 2000-11-28 | 2003-02-15 | 한국생명공학연구원 | 천연 생약제 추출물을 포함하는 숙취해소용 조성물 및이를 유효성분으로 함유하는 건강보조식품 |
| WO2005072758A1 (en) * | 2004-01-31 | 2005-08-11 | Kiyoung Kim | Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof |
| KR20070034146A (ko) * | 2005-09-23 | 2007-03-28 | 대우약품공업주식회사 | 항간독성 조성물 |
| WO2008044862A1 (en) * | 2006-10-10 | 2008-04-17 | Hanall Pharmaceutical Co., Ltd. | Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| KR20100008356A (ko) * | 2008-07-15 | 2010-01-25 | 한올제약주식회사 | 칼슘채널길항제를 포함하는 약제학적 제제 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010082785A2 (ko) | 2010-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275854A (en) | Pharmaceutical composition and its administration | |
| IL200171A (en) | Actriib-derived variables, pharmaceutical preparations containing them and their uses for the preparation of medicines | |
| EP2045251A4 (en) | COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS | |
| ZA200809002B (en) | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof | |
| EP2056835A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| AP2008004671A0 (en) | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof | |
| AP2714A (en) | Orodispersible pharmaceutical composition for or omucosal or sublingual administration of agomelati ne | |
| IL195237A0 (en) | Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same | |
| ZA200900345B (en) | Preparation of pharmaceutical formulations | |
| IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
| HK1126975A1 (en) | Pharmaceutical compositions with enhanced stability | |
| EP2211852A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING HEPATOTOXICITY ASSOCIATED WITH DRUG ADMINISTRATION | |
| WO2012010669A3 (de) | Arzneimittel zur oralen verabreichung umfassend ein gemisch aus silodosin und einem basischen copolymer | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| HK1131030A1 (en) | Packaging system for pharmaceutical compositions and kit for intravenous administration | |
| EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| EP2114374A4 (en) | PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE | |
| ZA200901083B (en) | Modified release pharmaceutical composition of bupropion hydrochloride | |
| WO2010079433A3 (en) | Pharmaceutical composition comprising melogliptin | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| PL2008655T3 (pl) | Kompozycja farmaceutyczna zawierająca środek przeciwbólowy i witaminy | |
| WO2010082785A3 (ko) | 경구용 약학적 조성물 | |
| EP2114404A4 (en) | COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| EP2343076A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| EP1948199A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10731400 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 10731400 Country of ref document: EP Kind code of ref document: A2 |